Sign In
News Digest /
StockInvest.us
Author: StockInvest.us
09:04am, Thursday, May 15, 2025
Kineta, Inc. (NASDAQ: YMTX) - Financial Overview (Q1 2025)
Kineta, Inc. continues to navigate significant challenges while exploring strategic alternatives to enhance shareholder value. The company reported its financial results for the quarter ending March 31, 2025, reflecting both positive init...
09:04am, Thursday, May 15, 2025
Company Overview
Lantern Pharma Inc. (NASDAQ: LTRN) is a biotechnology company focused on the development of cancer therapies using artificial intelligence (AI). The firm aims to accelerate oncology drug discovery and development through its proprietary RADR® platform, which utilizes extensive da...
09:03am, Thursday, May 15, 2025
Company Overview:
The Glimpse Group, Inc. (NASDAQ: VRAR) is an immersive technology company focused on Virtual Reality (VR), Augmented Reality (AR), and Spatial Computing software and services.
Financial Highlights (for the three months ended March 31, 2025 vs. 2024):
Total Revenue: $1.42 millio...
09:03am, Thursday, May 15, 2025
GRI Bio, Inc. (NASDAQ: VLON) has recently provided an update on its financial performance for the quarter ending March 31, 2025.
Positive Aspects:
Research and Development Focus: GRI Bio is actively developing innovative therapies aimed at inflammatory and autoimmune diseases, with promising cli...
09:02am, Thursday, May 15, 2025
Ondas Holdings Inc. (NASDAQ: ONDS) Overview
As of March 31, 2025, Ondas Holdings operates in the fields of private wireless, drone, and automated data solutions through its subsidiaries: Ondas Networks Inc. and Ondas Autonomous Systems Inc. The company has recently faced significant operational c...
09:02am, Thursday, May 15, 2025
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) has reported its quarterly performance for the period ending March 31, 2025. This analysis will highlight both the positive and negative aspects of the company's income statement.
Key Points and Statistics:
Revenue: $2.3 million (down from $3.4 million ...
09:01am, Thursday, May 15, 2025
Company Overview:
Atara Biotherapeutics, Inc. (NASDAQ: ATRA) is a leader in T-cell immunotherapy, focusing on developing transformative therapies for patients with cancer and autoimmune diseases. The company's lead program, tab-cel (tabelecleucel), has received marketing authorization in certain ...
09:01am, Thursday, May 15, 2025
HeartCore Enterprises, Inc. (NASDAQ: HTCR) has recently released its quarterly financials for the period ended March 31, 2025. Here's a brief overview of the company's current financial situation, highlighting both positive and negative aspects based on the latest income statement.
Key Financial ...
09:00am, Thursday, May 15, 2025
Agriculture & Natural Solutions Acquisition Corporation (NYSEARCA: DCRE)
As of March 31, 2025, Agriculture & Natural Solutions Acquisition Corporation continues its operations as a blank check company focused on completing a merger, acquisition, or similar business combination. Here’s a breakdown...
09:00am, Thursday, May 15, 2025
Sino Green Land Corporation (PINK: SGLA) has recently reported its third-quarter financial results for the period ending March 31, 2025. The company is engaged in recycling and environmental technologies, primarily focused on plastic waste management.
Key Financial Highlights:
Net Revenues: $197...
08:08am, Thursday, May 15, 2025
**Galera Therapeutics, Inc.** (NASDAQ: GRTX) has reported its quarterly financial results for the period ending March 31, 2025. Below are the key highlights and insights derived from the income statement and company information.
Positive Aspects:
Significant reduction in net loss from $4.38 mill...
08:08am, Thursday, May 15, 2025
SINTX Technologies, Inc. (NASDAQ: SINT) has recently reported its financial performance for the first quarter of 2025. The company focuses on advanced ceramics for biomedical and antipathogenic applications, having evolved from purely manufacturing medical devices to leveraging silicon nitride te...
08:07am, Thursday, May 15, 2025
Elevation Oncology, Inc. (NASDAQ: ELEV) is navigating through challenging waters as reflected in its recent quarterly results. Here are some key developments and statistics regarding the company's financial performance.
Positive Aspects:
Increase in Cash Position: As of March 31, 2025, cash and ...
08:07am, Thursday, May 15, 2025
Company Overview
Hennessy Capital Investment Corp. VI (NASDAQ: HCVIW) is a Special Purpose Acquisition Company (SPAC) incorporated to effect a merger, stock exchange, asset acquisition, or similar business combination with one or more businesses. The firm is currently seeking a target business fo...
08:06am, Thursday, May 15, 2025
Cabaletta Bio, Inc. (NASDAQ: CABA) Overview
Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on developing engineered T cell therapies for autoimmune diseases. The company is advancing multiple product candidates, notably rese-cel, MuSK-CAART, and DSG3-CAART. Despite promisin...
